Showing 971-980 of 4167 results for "".
MATV News: The Art of Injecting; Chemicals in Beauty Products; Neurotoxin Pipeline
https://beta.modernaesthetics.com/series/matv-news/matv-news-the-art-of-injecting-chemicals-in-beauty-products-neruotoxin-pipeline/33322/A highly detailed body painting project is helping physicians better improve botulinum toxin injection techniques, a new study shows women with skin of color have higher levels of beauty-product related chemicals in their bodies, and a neuromodulator in the pipeline is showing promise. And, a look aMATV News: New CEOs at Top-Tier Aesthetic Companies; Allergan Vollure Launch and Other News
https://beta.modernaesthetics.com/series/matv-news/matv-news-new-ceos-at-top-tier-aesthetic-companies-allergan-vollure-launch-and-other-news/33342/Both Merz North America and Revision Skincare introduce new CEOs and Apax Partners buy all outstanding shares of Syneron stock. Also in this episode, Allergan launches Juvéderm Vollure and announces new Senior Vice President of Global Investor Relations and Strategy. Plus, is there a golden ratio whMATV News: Allergan Acquires Zeltiq; The Formula for Attractive Lips
https://beta.modernaesthetics.com/series/matv-news/matv-news-allergan-acquires-zeltiq-the-formula-for-attractive-lips/33348/Acquisitions top aesthetic news with Allergan acquiring Zeltiq and Hologic buying Cynosure along with rumors that Syneron is on the block. What do these acquisitions mean for the field? Also in this episode, new research assesses what measurements create the most attractive female lips and we look aPredictions and Predilections
https://modernaesthetics.com/ma-issues-index/2017-jan-feb/predictions-and-predilections/34315/Aesthetic experts foretell what's in store for 2017.MATV News: New Natrelle Inspira Implants from Allergan; RT002 Trials for Frown Lines
https://beta.modernaesthetics.com/series/matv-news/matv-news-new-natrelle-inspira-implants-from-allergan-rt002-trials-for-frown-lines/33350/The FDA has approved Allergan's Natrelle Inspira SoftTouch breast implants. Two double-blind, placebo-controlled Phase 3 trials are now underway to evaluate daxibotulinumtoxinA (RT002) from Revance Therapeutics for the treatment of glabellar lines. Also, Venus Concept is bringing its Venus VelocityMATV News: Juvéderm Volbella XC Now Available; Gluteal Fat Grafting Task Force Forms
https://beta.modernaesthetics.com/series/matv-news/matv-news-juv-derm-volbella-xc-now-available-gluteal-fat-grafting-task-force-forms--estovege/33356/Juvéderm Volbella XC is now available for lip augmentation and correction of perioral rhytids. Also, the Aesthetic Surgery Education and Research Foundation forms a Gluteal Fat Grafting Task Force in response to high mortality rates seen with Brazilian butt lifts, Biologica Technologies introduces iMATV News: VCS Highlights; Volbella XC Approved
https://beta.modernaesthetics.com/series/matv-news/matv-news-vcs-highlights-volbella-xc-approved/33409/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we cover the recent Vegas Cosmetic Surgery meeting as well as the FDA approval of Allergan's Juvéderm Volbella XC for lip augmentation and for correction of perioral rhytids. Also in this episode, Galderma celebrates RestTechnology Rocks
https://modernaesthetics.com/ma-issues-index/2016-may-june/technology-rocks/34403/Shorr bets to boost efficiency and productivity.Balancing Act
https://modernaesthetics.com/ma-issues-index/2016-may-june/balancing-act/34395/As society changes, so too does what it means to be a doctor.In the Heat of the Micro-moment
https://modernaesthetics.com/ma-issues-index/2016-may-june/in-the-heat-of-the-micro-moment/34399/The smartphone revolution has created a lot of buzz about “micro-moments” and “near me” or “mobile-centric” searches.